Item 7.01 Regulation FD Disclosure.

On November 18, 2008, Candela Corporation issued a press release announcing that the United States District Court for the District of Massachusetts agreed to stay the patent litigation that Palomar Medical Technologies, Inc. ("Palomar") brought against the Company in August 2006. In that suit, Palomar asserts that the Company infringed upon U.S. Patent No. 5,735,844 (the '"844 Patent") and U.S. Patent No. 5,595,568, which is related to the '844 Patent (the '"568 Patent").

The Company filed a motion requesting a stay of the lawsuit on October 31, 2008 after learning of a third party's re-examination request that was filed with the United States Patent and Trademark Office (the "PTO") on July 10, 2008, which was granted by the PTO on August 29, 2008. A copy of the press release is furnished herewith as Exhibit 99.1 to this report.

The information in this Section, including the exhibit attached hereto, in this Current Report is being furnished and shall not be deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liability of that Section, and shall not be incorporated by reference into any registration statement or other document filed under the Securities Act of 1933, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.

Item 9.01 Financial Statements and Exhibits

A copy of the press release issued by Candela Corporation on November 18, 2008 is attached to this report.

---